QNRX
Quoin Pharmaceuticals Ltd DRC
NASDAQ: QNRX · HEALTHCARE · BIOTECHNOLOGY
$6.21
-4.17% today
Updated 2026-05-01
Market cap
$9.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.80
Dividend yield
—
52W range
$5 – $24
Volume
0.1M
Quoin Pharmaceuticals Ltd DRC (QNRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $-280000.00 | — | $-280000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | +100.0% | — | +100.0% | — | — | — | — | — | — |
| Cost of revenue | $18271.00 | $89130.00 | $104223.00 | $125720.00 | $227055.00 | $104773.00 | $104115.00 | $103635.00 | $103438.00 | $100474.00 | $100793.00 |
| Gross profit | $-18271.00 | $-280000.00 | $-104223.00 | $-280000.00 | $-227055.00 | $-104773.00 | $-104115.00 | $-103635.00 | $-103438.00 | $-100474.00 | $-100793.00 |
| Gross margin | — | 100.0% | — | 100.0% | — | — | — | — | — | — | — |
| R&D | $1.52M | $8.26M | $5.89M | $8.26M | $45650.00 | $244155.00 | $1.56M | $2.67M | $3.31M | $3.60M | $9.80B |
| SG&A | — | $7.97M | $4.20M | $7.97M | $1.51M | $1.43M | $4.50M | $6.58M | $6.07M | $5.93M | $6.49B |
| Operating income | $-2.60M | $15.32M | $10.17M | $15.32M | $-1.56M | $-1.67M | $-6.06M | $-9.26M | $-9.38M | $-9.53M | $-16.42M |
| Operating margin | — | -5470.4% | — | -5470.4% | — | — | — | — | — | — | — |
| EBITDA | $-2.60M | $15.32M | $10.17M | $15.32M | $-1.54M | $-1.57M | $-20.27M | $-8.56M | $-9.27M | $-9.43M | $-16.32M |
| EBITDA margin | — | -5470.4% | — | -5470.4% | — | — | — | — | — | — | — |
| EBIT | $-2.62M | $15.32M | $10.17M | $15.32M | $-1.77M | $-1.67M | $-20.37M | $-8.67M | $-9.38M | $-9.53M | $-16.42M |
| Interest expense | — | — | — | — | $412292.00 | $1.19M | $1.09M | $714081.00 | $0.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.62M | $15.32M | $10.17M | $15.32M | $-1.56M | $-2.10M | $-21.46M | $-9.38M | $-8.69M | $-8.96M | $-15.80B |
| Net income growth (YoY) | — | +685.1% | -33.6% | +50.6% | -110.2% | -34.3% | -924.3% | +56.3% | +7.4% | -3.2% | -176242.6% |
| Profit margin | — | -5470.4% | — | -5470.4% | — | — | — | — | — | — | — |